Search

Search Constraints

You searched for: Author/Creator Such, E.

Search Results

1. Impact of DNMT3A and IDH1/IDH2 Mutations on Treatment Response with Azacitidine in Myeloid Neoplasms. (April 2017)

2. Interpretation of NGS Results for Clinical Practice in Myelodysplastic Syndromes. (April 2017)

3. Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries. (April 2017)

4. Chronic GVHD Could Ameliorate the Impact of Adverse Somatic Mutations in Patients with Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation. (April 2017)

5. Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes. (April 2017)

6. A Single Next-Generation Sequencing (NGS) Assay for the Detection of Point Mutations and Large Chromosomal Abnormalities in MDS Patients. (April 2017)

7. Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML. (April 2017)

10. PB1918: MOLECULAR CHARACTERIZATION AND CLINICAL RELEVANCE OF ERYTHROPOIESIS IN MIELODYSPLASTIC SYNDROMES. (23rd June 2022)